According to Dr. Reddy's's latest financial reports the company's current revenue (TTM) is $3.28 B. In 2022 the company made a revenue of $2.97 B an increase over the years 2021 revenue that were of $2.79 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $3.28 B | 10.54% |
2022 | $2.97 B | 6.22% |
2021 | $2.79 B | 11.47% |
2020 | $2.50 B | 3.16% |
2019 | $2.43 B | 12.53% |
2018 | $2.16 B | -1.76% |
2017 | $2.19 B | 3.37% |
2016 | $2.12 B | -11.74% |
2015 | $2.41 B | 2.3% |
2014 | $2.35 B | 7.18% |
2013 | $2.19 B | 14.83% |
2012 | $1.91 B | 1.82% |
2011 | $1.88 B | 19.68% |
2010 | $1.57 B | 2.82% |
2009 | $1.52 B | 8.26% |
2008 | $1.41 B | 10.44% |
2007 | $1.27 B | 2.15% |
2006 | $1.25 B | 141.77% |
2005 | $0.51 B | 17.47% |
2004 | $0.44 B | 13.82% |
2003 | $0.38 B | 81.71% |
2002 | $0.21 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Novartis NVS | $51.01 B | 1,453.72% | ๐จ๐ญ Switzerland |
Pfizer PFE | $58.49 B | 1,681.70% | ๐บ๐ธ USA |
Sanofi SNY | $50.35 B | 1,433.86% | ๐ซ๐ท France |
GlaxoSmithKline GSK | $37.84 B | 1,052.80% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $15.84 B | 382.64% | ๐ฎ๐ฑ Israel |